Sign in Create account

Citurgia Biochemicals Ltd.

Chemicals · Chemicals & Petrochemicals

BSE: 506373
₹104.45
▼ -1.05 (-1.00%)
Sept. 28, 2026 · BSE · bse_bhavcopy
Quality
18/100
Weak
Valuation
—/100
Data unavailable
Momentum
9/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,380 Cr
PE (TTM)
Data unavailable.
Price to Book
-178.4
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-31.8
Free Cash Flow
₹-0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (238 companies)
EPS Growth (YoY)
100.00%
as of March 31, 2026
Industry median 39.08% (220 companies)
Net Profit Growth (TTM)
-64.90%
as of June 30, 2026
Industry median 13.45% (212 companies)
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
-116.81%
as of March 31, 2026
Industry median 23.11% (213 companies)
Revenue Growth (YoY)
Data unavailable.
Current Ratio
0.87
as of March 31, 2026
Industry median 1.87 (237 companies)
Debt to Equity
-0.89
as of March 31, 2026
Industry median 0.16 (224 companies)
Interest Coverage
-4659.00
as of Dec. 31, 2024
Industry median 8.97 (221 companies)
Net Margin
-8900.00%
as of Sept. 30, 2007
Industry median 7.49% (212 companies)
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
-7.34%
as of March 31, 2026
Industry median 4.33% (217 companies)
Return on Capital Employed
-80.41%
as of March 31, 2026
Industry median 10.34% (218 companies)
Return on Equity
9.94%
as of March 31, 2026
Industry median 7.52% (219 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (-0.89)
  • No Return on equity is 15% or more (9.9%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 2 met
  • No 1-year return beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.0%
Low 104.4500 · High 105.5000
1W return
-1.0%
Low 104.4500 · High 105.5000
1M return
-3.9%
Low 104.4500 · High 107.6000
52W return
-34.0%
Low 104.4500 · High 111.9000
Lifetime High ₹431.7500 (Nov. 25, 2009)
Lifetime Low ₹15.2500 (April 4, 2007)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
108.9
10D
117.7
20D
129.0
50D
144.5
100D
155.2
200D
167.7

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
98.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

104.80
Pivot
First resistance105.15
Second resistance105.85
Third resistance106.20
First support104.10
Second support103.75
Third support103.05
Day RSI27.7
Day MFI18.3
Day MACD-12.91
Day MACD signal-9.19

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

↓ -3.9%
Over 1 Month
LowHigh
104.45107.60
↓ -34.0%
Over 3 Months
LowHigh
104.45111.90
↓ -34.0%
Over 6 Months
LowHigh
104.45111.90
↓ -34.0%
Over 1 Year
LowHigh
104.45111.90
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹0.0000

Ranks #75 of 221 in Chemicals & Petrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter99.36%

Largest holders

NameCategoryShares %Shares
SATYA SHEEL ENGINEERS AND MINERS PRIVATE LIMITEDPromoter60.6400%80100000
DEV VERSHA JETRO VALLEY PRIVATE LIMITEDPromoter27.1400%35850000
GANDHARVA HOLDING LIMITEDPromoter5.7900%7650000
GEM INFO SOLUTIONS PRIVATE LIMITEDPromoter5.7500%7600000
ELITE CAPITAL & MANAGEMENT SERVICES LIMITEDPromoter0.0400%50000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 99.36% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Board Meeting Citurgia Biochemicals Ltd - 506373 - Board Meeting Intimation for To Consider The Matter Of Conducting Annual General Meeting Of The Company
30 Sep 2026 Insider Trading / SAST Citurgia Biochemicals Ltd - 506373 - Closure of Trading Window
25 Sep 2026 Company Update Citurgia Biochemicals Ltd - 506373 - Additional Details Required For Corporate Announcement Dated 18Th September, 2026 Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
8 Sep 2026 Company Update Citurgia Biochemicals Ltd - 506373 - Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Sep 2026 Company Update Citurgia Biochemicals Ltd - 506373 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (9.9%)
  • Thin net profit margin (-8900.0%)
  • Negative shareholder equity (Debt/Equity -0.89) -- accumulated losses exceed paid-in capital
  • Tight liquidity (Current Ratio 0.87)
  • Declining profit YoY (-116.8%)

Opportunities

  • RSI in oversold territory (27.7) -- a technical rebound zone

Threats

  • Down 34.0% over the past year
  • Weak interest coverage (-4659.0x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Citurgia Biochemicals Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.